125,000 Shares in Acuren Corp $TIC Purchased by Nkcfo LLC

Nkcfo LLC bought a new position in shares of Acuren Corp (NYSEAMERICAN:TIC) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 125,000 shares of the company’s stock, valued at approximately $1,664,000.

Other hedge funds also recently added to or reduced their stakes in the company. Clearstead Advisors LLC purchased a new stake in shares of Acuren during the 3rd quarter worth approximately $43,000. Ameritas Investment Partners Inc. raised its holdings in Acuren by 34.8% during the third quarter. Ameritas Investment Partners Inc. now owns 14,242 shares of the company’s stock worth $190,000 after purchasing an additional 3,673 shares during the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management purchased a new stake in Acuren during the third quarter worth $153,000. CenterBook Partners LP acquired a new stake in Acuren in the third quarter valued at $1,796,000. Finally, Cercano Management LLC acquired a new stake in Acuren in the third quarter valued at $38,629,000.

Acuren Trading Down 5.8%

Shares of NYSEAMERICAN TIC opened at $9.21 on Tuesday. The company has a 50-day simple moving average of $10.33 and a 200-day simple moving average of $10.99. Acuren Corp has a 12 month low of $8.76 and a 12 month high of $14.94.

Analyst Ratings Changes

TIC has been the subject of several research reports. Zacks Research raised Acuren to a “hold” rating in a research note on Tuesday, December 16th. Jefferies Financial Group restated a “buy” rating and set a $15.00 target price on shares of Acuren in a research report on Friday, November 14th. JPMorgan Chase & Co. assumed coverage on shares of Acuren in a research report on Friday, January 9th. They issued an “overweight” rating and a $16.00 price target on the stock. Finally, UBS Group dropped their price objective on shares of Acuren from $15.00 to $11.50 and set a “neutral” rating for the company in a research note on Friday, November 14th. Two analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $14.38.

About Acuren

Acuren Group Inc (NYSEAMERICAN:TIC) is a leading provider of non‐destructive testing (NDT), inspection, engineering and consulting services to the energy, petrochemical, manufacturing and infrastructure sectors. The company employs a range of advanced testing techniques—such as ultrasonic, radiographic, magnetic particle, liquid penetrant, eddy current and acoustic emission—to evaluate the integrity of pressure vessels, pipelines, storage tanks and other critical assets. By combining field inspections with laboratory analysis, Acuren helps clients identify defects, prevent equipment failures and meet regulatory requirements.

In addition to core NDT capabilities, Acuren offers specialty engineering and consulting services including fitness‐for‐service assessments, corrosion under insulation surveys, mechanical integrity programs, failure analysis and field machining.